Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Stock Attack -- A Complete Analysis -- Ignore unavailable to you. Want to Upgrade?

To: Sonki who wrote (18985)	1/22/1999 7:54:00 PM
From: Judy	Read Replies (1) \| Respond to of 42787

Sonki, the drug sector will show muted price action until the new drugs in the pipelines gain a higher profile and the market anticipates future revenues. I'd expect the drug sector to underperform while the market is churning but some drug stocks will lead based on what's in their pipelines when the market is ready to resume its upward course. While macroeconomic conditions remain benign or healthy, defensive stocks cannot outperform the market. The news on MRK is company-specific, the analysts will factor out how future revenues will be impacted with the company not moving forward with the phase III trials and the selling mood of the market will take the price even lower.

To: Sonki who wrote (18985)	1/22/1999 11:26:00 PM
From: Michael Rich	Read Replies (1) \| Respond to of 42787

Sonki, I'm looking for some investment opps and the big pharmas are the ones I'd like to put some money in and forget about it. The technical picture is not pretty so no idea of how they will perform this year. Long term I'm very bullish about this sector because I witness exciting things are happening in biomedical research. Big pharmas have the money to turn the research into profit. Some selected biotech co's will also do very well... For example, human genome project will be done sooner than expected, maybe 2002-2003, this will have a huge impact on health care... and you know the world is aging too. BTW, MRK dropped from 145 to 139 after NYSE was closed.